Nagashree Seetharamu

17PUBLICATIONS
46CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMolecular targetsPredictive and prognostic markersPacific Peoples social determinants of health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 01, 2026
Standard Versus Reduced Sotorasib Dosing in KRAS G12C-Mutated Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis-Have We Answered the Dosing Question?

|Mar 19, 2026
Near-complete pathologic resolution of untreated papillary thyroid cancer after pembrolizumab-induced thyroiditis.

Margaret Locke, Sara Sternbach, Nagashree Seetharamu

|May 22, 2025
Randomized Phase Ib Clinical Trial of DB-020 Intratympanic Injections to Reduce High-Dose Cisplatin Ototoxicity.

Benedict J Panizza, Stephen John O'Leary, Christopher David Hart

|Nov 09, 2023
Profile of Capmatinib for the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC): Patient Selection and Perspectives.

Madison Fraser, Nagashree Seetharamu, Matthew Diamond

|Jul 30, 2023
Efficacy and tolerability of a low dose weekly paclitaxel, carboplatin and cetuximab (PCC) regimen for metastatic or unresectable head and neck squamous cell carcinomas.

Margaret Locke, Nina Kohn, Nagashree Seetharamu

|Apr 11, 2023
Efficacy of ketamine mouthwash in the management of oral and pharyngeal toxicity associated with head and neck chemoradiotherapy: protocol for a phase II, Simon's two-stage trial.

Daniel Koffler, Jacob Eckstein, Joseph Herman

Pageof 3

Frequent Collaborators

4 joint publications

Chung-Shien Lee

4 joint publications

Coral Olazagasti

2 joint publications

Margaret Locke

1 joint publications

Carolina Bernabe